Skip to main content

Other Varieties of Dysfunction

  • Chapter
  • First Online:
Bladder Dysfunction in the Adult

Part of the book series: Current Clinical Urology ((CCU))

  • 921 Accesses

Abstract

Overactive bladder (OAB) is urgency, with or without urgency incontinence, usually with increased daytime frequency and nocturia. The key symptom of OAB is urgency, which is the complaint of a sudden compelling desire to pass urine which is difficult to defer. OAB is different from detrusor overactivity (DO), which is a urodynamic diagnosis, comprising bladder contractions during the filling phase, which may be spontaneous or provoked. Various underlying mechanisms have been hypothesised, including myogenic, neurogenic and integrative (autonomous) processes. Detrusor underactivity (DUA) is a contraction of reduced strength and/or duration resulting in prolonged bladder emptying and/or failure to achieve complete bladder emptying within a normal time span. Underlying mechanisms are uncertain, and it is likely to be multifactorial. Voiding problems can result from dysfunction of the bladder neck or sphincter. In patients with neurological disease, there may be detrusor sphincter dyssynergia. Nocturia is the complaint that the individual has to wake at night one or more times to void and can be caused by polyuria, nocturnal polyuria or lower urinary tract problems.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abrams P, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.

    Article  PubMed  Google Scholar 

  2. Abrams P, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187(1):116–26.

    Article  PubMed  Google Scholar 

  3. Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol. 2006;175(1):191–4; discussion 194–195.

    Article  CAS  PubMed  Google Scholar 

  4. Parsons BA, Drake MJ. Animal models in overactive bladder research. Handb Exp Pharmacol. 2011;202:15–43.

    Article  CAS  PubMed  Google Scholar 

  5. de Groat WC. A neurologic basis for the overactive bladder. Urology. 1997;50(6A Suppl):36–52; discussion 53–56.

    Article  PubMed  Google Scholar 

  6. Brading AF, Turner WH. The unstable bladder: towards a common mechanism. Br J Urol. 1994;73(1):3–8.

    Article  CAS  PubMed  Google Scholar 

  7. Brading AF. A myogenic basis for the overactive bladder. Urology. 1997;50(6A Suppl):57–67; discussion 68–73.

    Article  CAS  PubMed  Google Scholar 

  8. Drake MJ, Mills IW, Gillespie JI. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet. 2001;358(9279):401–3.

    Article  CAS  PubMed  Google Scholar 

  9. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.

    CAS  PubMed  Google Scholar 

  10. Irwin DE, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–14; discussion 1314–1315.

    Article  PubMed  Google Scholar 

  11. Drake MJ, Abrams P. Overactive bladder. In: Alan J, Wein W, McDougal S, Kavoussi LR, Novick AC, editors. Campbell-Walsh urology. 10th ed. Philadelphia, PA: WB Saunders; 2011. Ch 66.

    Google Scholar 

  12. Abrams P, et al. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6(11 suppl):S580–90.

    CAS  PubMed  Google Scholar 

  13. Brown JS, et al. Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc. 2000;48(7):721–5.

    CAS  PubMed  Google Scholar 

  14. Abrams P, Klevmark B. Frequency volume charts: an indispensible part of lower urinary tract assessment. Scand J Urol Nephrol Suppl. 1996;179:47–53.

    CAS  PubMed  Google Scholar 

  15. Hashim H, Abrams P. Overactive bladder: an update. Curr Opin Urol. 2007;17(4):231–6.

    Article  PubMed  Google Scholar 

  16. Yamaguchi O, et al. Clinical guidelines for overactive bladder. Int J Urol. 2009;16(2):126–42.

    Article  CAS  PubMed  Google Scholar 

  17. Gulur DM, Drake MJ. Management of overactive bladder. Nat Rev Urol. 2010;7(10):572–82. Review.

    Article  CAS  PubMed  Google Scholar 

  18. Sahai A, Dowson C, Khan MS, Dasgupta P. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial. BJU Int. 2009;103(11):1509–15.

    Article  CAS  PubMed  Google Scholar 

  19. Bramble FJ. The clam cystoplasty. Br J Urol. 1990;66(4):337–41.

    Article  CAS  PubMed  Google Scholar 

  20. Singh G, Wilkinson JM, Thomas DG. Supravesical diversion for incontinence: a long-term follow-up. Br J Urol. 1997;79(3):348–53.

    Article  CAS  PubMed  Google Scholar 

  21. Thomas AW, et al. The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostate within a minimum 10 year urodynamic follow up. BJU Int. 2004;93:745–50.

    Article  CAS  PubMed  Google Scholar 

  22. Lluel P, et al. Increased adrenergic contractility and decreased mRNA expression of NOSIII in ageing rat bladders. Fundam Clin Pharmacol. 2003;17:633–41.

    Article  CAS  PubMed  Google Scholar 

  23. Elbadwi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction II. Aging detrusor: normal vs impaired contractility. J Urol. 1993;150:1657–67.

    Google Scholar 

  24. Kuchel GA. Hazzard’s principals of geriatric medicine and gerontology. 6th ed. New York: McGraw-Hill; 2009. p. 621–30.

    Google Scholar 

  25. Schneider T, et al. A role for muscarinic receptors or rho-kinase in hypertension associated rat bladder dysfunction? J Urol. 2005;173:2178–81.

    Article  CAS  PubMed  Google Scholar 

  26. Malone-Lee J, Wahenda I. Characterisation of detrusor contractile function in relation to old age. Br J Urol. 1993;72:966–7.

    Article  Google Scholar 

  27. Diokno AC, et al. Prevalence of urinary incontinence in the non-institutionalised elderly. J Urol. 1986;136:1022–5.

    CAS  PubMed  Google Scholar 

  28. van Koeveringe GA, et al. Detrusor underactivity: a plea for new approaches to a common bladder dysfunction. Neurourol Urodyn. 2011;30:723–8.

    Article  PubMed  Google Scholar 

  29. FitzGerald MP, Brubaker L. The etiology of urinary retention after surgery for genuine stress incontinence. Neurourol Urodyn. 2001;20:13–21.

    Article  CAS  PubMed  Google Scholar 

  30. Abrams P. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int. 1999;84(1):14–5.

    Article  CAS  PubMed  Google Scholar 

  31. Griffiths DJ, van Mastrigt R, Bosch R. Quantification of urethral resistance and bladder function during voiding, with special reference to the effects of prostate size reduction on urethral obstruction due to benign prostatic hyperplasia. Neurourol Urodyn. 1989;8:29–52.

    Article  Google Scholar 

  32. Schafer W. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol. 1995;13:47–58.

    Article  CAS  PubMed  Google Scholar 

  33. Anderson K-E, et al. Pharmacological treatment of urinary incontinence. In: Abrahms P, Khoury S, Wein A, editors. Incontinence 3rd international consultation on incontinence. Plymouth: Plymouth Distributors Ltd; 2005. p. 811.

    Google Scholar 

  34. Katona F, Eckstein HB. Treatment of neuropathic bladder by transurethral electrical stimulation. Lancet. 1974;1:780–1.

    Article  CAS  PubMed  Google Scholar 

  35. Everaert K, et al. The urodynamic evaluation of neuromodulation in patients with voiding dysfunction. Br J Urol. 1997;79:702–7.

    Article  CAS  PubMed  Google Scholar 

  36. Stenzl A, et al. Restoration of voluntary emptying of the bladder by transportation of innervated free skeletal muscle. Lancet. 1998;351:1483–5.

    Article  CAS  PubMed  Google Scholar 

  37. Elbadawi A, Yalla SV, Resnick NM. Structural basis of geriatric voiding dysfunction I-III. Detrusor overactivity. J Urol. 1993;150:1650–80.

    CAS  PubMed  Google Scholar 

  38. Resnick NM, Yalla SV, Laurino E. The pathophysiology and clinical correlates of established urinary incontinence in frail elderly. N Engl J Med. 1989;320:1–7.

    Article  CAS  PubMed  Google Scholar 

  39. Resnick NM, Yalla SV. Detrusor hyperactivity with impaired contractility; an unrecognized but common cause of incontinence in elderly patients. JAMA. 1987;257:3076–81.

    Article  CAS  PubMed  Google Scholar 

  40. Griffiths DJ, McCracken PN, Harrison GM, Ann Gormley E, Moore KN. Urge incontinence and impaired detrusor contractility in the elderly. Neurourol Urodyn. 2002;21:126–31.

    Article  PubMed  Google Scholar 

  41. Resnick NM, Yalla SV. Geriatric incontinence and voiding dysfunction. In: Walsh P, Retik A, Vaughan Jr ED, Wein AJ, editors. Campbell’s urology, vol. 2. 8th ed. Philadelphia, PA: WB Saunders; 2002. p. 1222–3. Ch 36.

    Google Scholar 

  42. Resnick NM, et al. Misdiagnosis of urinary incontinence in nursing home women: prevalence and proposed solution. Neurourol Urodyn. 1996;15:599–618.

    Article  CAS  PubMed  Google Scholar 

  43. Brandeis GH, Yalla SV, Resnick NM. Detrusor hyperactivity with impaired contractility (DHIC): the great mimic. J Urol. 1990;143:223A.

    Google Scholar 

  44. Payne CK. Behavioural therapy for overactive bladder. Urology. 2000;55(5A):3–6.

    Article  CAS  PubMed  Google Scholar 

  45. Fantl JA, Newman DK, Colling J. Urinary incontinence in adults: acute and chronic management. (Clinical practice guideline, Mo.2, 1996 Update, AHCPR Publication No. 96-0682). Rockville, MD: U.S. Department of health and human services, Public health service, Agency for health care policy and research; 1996.

    Google Scholar 

  46. Miller KL, et al. Dose titration key to oxybutynin efficacy for geriatric incontinence, even for DHIC. Neurourol Urodyn. 2000;19:538–9 (Abstract).

    Google Scholar 

  47. Wein AJ. Neuromuscular dysfunction of the lower urinary tract and its management. In: Walsh PC, Retik AB, Darracot Vaughan Jr E, Wein AJ, editors. Campell’s urology, vol. 2. 8th ed. Philadelphia, PA: WB Saunders; 2002. p. 957–8.

    Google Scholar 

  48. Turner-Warwick RT, et al. A urodynamic view if the clinical problems associated with bladder neck dysfunction and its treatment by endoscopic incision and trans-trigonal posterior prostatectomy. Br J Urol. 1973;44:45–9.

    Google Scholar 

  49. Trockman BA, et al. Primary bladder neck dysfunction: urodynamic finding and treatment results in 26 men. J Urol. 1996;156:1418–20.

    Article  CAS  PubMed  Google Scholar 

  50. Bates CP, Arnold EP, Griffiths DJ. The nature of the abnormality in bladder neck obstruction. Br J Urol. 1975;47:651–5.

    Article  CAS  PubMed  Google Scholar 

  51. Turner-Warwick RT. Bladder outflow obstruction in the male. In: Mundy AR, Stephenson TP, Wein AJ, editors. Urodynamic principles, practice and application. London: Churchill Livingstone; 1984. p. 183–204.

    Google Scholar 

  52. Wein AJ, Rovner ES. Adult voiding dysfunction secondary to neurologic disease or injury. AUA Update series, vol 18, lesson 6. Houston: American Urological Association, Inc.; 1999. pp. 42–7.

    Google Scholar 

  53. Blavias JG, Sinha HP, Zayed AA, et al. Detrusor sphincter dyssynergia. J Urol. 1981;125:541–5.

    Google Scholar 

  54. Chancellor MB, Rivas DA. Current management of detrusor-sphincter dyssynergia. In: McGuire E, editor. Advances in urology. St. Louis: CV Mosby; 1995. p. 291–324.

    Google Scholar 

  55. Nambirajan T, et al. Urethral stents for urethral sphincter dyssynergia. BJU Int. 2005;95:350–3.

    Article  PubMed  Google Scholar 

  56. Van Kerrebroek P. The standardization of terminology in nocturia: report from the standardization subcommittee of the International Continence Society. BJU Int. 2002;90 Suppl 3:11–5.

    Article  Google Scholar 

  57. Malmsten UG, et al. Urinary incontinence and lower urinary tract symptoms: an epidemiological study of men aged 45 to 99. J Urol. 1997;158:1733–7.

    Article  CAS  PubMed  Google Scholar 

  58. Swithenbank LV, et al. Female urinary symptoms: age prevalence in a community dwelling population using a validated questionnaire. Neurourol Urodyn. 1998;16:432–4.

    Google Scholar 

  59. Middlekoop HA, et al. Subjective sleep characteristics of 1485 males and females aged 50-93: effects of sex and age, and factors related to self-evaluated quality of sleep. J Gerontol A Biol Sci Med Sci. 1996;51:108–15.

    Article  Google Scholar 

  60. Jolleys JV, Donovan JL, Nanchahal K, Peters TJ, Abrams P. Urinary symptoms in the community: how bothersome are they? Br J Urol. 1994;74(5):551–5.

    Article  CAS  PubMed  Google Scholar 

  61. Kobelt G, Borgstrom F, Mattiasson A. Productivity, vitality and utility in a group of healthy professionally active individuals with nocturia. BJU Int. 2003;91(3):190–5.

    Article  CAS  PubMed  Google Scholar 

  62. Stewart RB, Moore MT, May FE, et al. Nocturia: a risk for falls in the elderly. J Am Geriatr Soc. 1992;40:1217–20.

    CAS  PubMed  Google Scholar 

  63. Weiss JP, Blaivas JG. Nocturnal polyuria versus overactive bladder in nocturia. Urology. 2002;60:28–32; discussion 32.

    Article  PubMed  Google Scholar 

  64. Appell RA, Sand PK. Nocturia: etiology, diagnosis and treatment. Neurourol Urodyn. 2008;27:34–9.

    Article  PubMed  Google Scholar 

  65. Weiss JP, Blaivas JG. Nocturia. J Urol. 2000;163:5–12.

    Article  CAS  PubMed  Google Scholar 

  66. Krieger JN, et al. Nocturnal polyuria is a symptom of obstructive sleep apnoea. Urol Int. 1993;50:93–7.

    Article  CAS  PubMed  Google Scholar 

  67. Donovan JL, Abrams P, Peters TJ, et al. The ICS-‘BPH’ study. The psychometric validity and reliability of the ICS male questionnaire. Br J Urol. 1996;77:554–62.

    Article  CAS  PubMed  Google Scholar 

  68. Hald T, Nordling J, Andersen JT, Bilde T, Meyhoff HH, Walter S. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl. 1991;138:59–62.

    CAS  PubMed  Google Scholar 

  69. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77:805–12.

    Article  CAS  PubMed  Google Scholar 

  70. Soda T, Masui K, Okuno H, et al. Efficacy of nondrug lifestyle measures for the treatment of nocturia. J Urol. 2010;184(3):1000–4.

    Article  PubMed  Google Scholar 

  71. Pederson PA, Johansen PB. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol. 1988;62:145–7.

    Article  Google Scholar 

  72. Lose G, et al. Efficacy of desmopressin (Minirin) in the treatment of nocturia: a double blind placebo- controlled study in women. Am J Obstet Gynecol. 2003;189:1106–13.

    Article  CAS  PubMed  Google Scholar 

  73. Rembratt A, Riis A, Norgaard JP. Desmopressin treatment on nocturia; an analysis of risk factors for hyponatraemia. Neurourol Urodyn. 2006;25:105–9.

    Article  CAS  PubMed  Google Scholar 

  74. Abrams P, Swift S. Solifenacin is effective for the treatment of OAB dry patients: a pooled analysis. Eur Urol. 2005;48:483–7.

    Article  CAS  PubMed  Google Scholar 

  75. Kaplan SA, Walmsley K, Te AE. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia. J Urol. 2005;174:2273–5.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan Williams M.B.B.S., B.Sc. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Williams, J. (2014). Other Varieties of Dysfunction. In: Wein, A., Andersson, KE., Drake, M., Dmochowski, R. (eds) Bladder Dysfunction in the Adult. Current Clinical Urology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0853-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0853-0_7

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-0852-3

  • Online ISBN: 978-1-4939-0853-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics